Komori
Other Disclosures2158FRONTEO,Inc.Information and Communications, Services and Others

FRONTEO Launches KIBIT BackStage, an AI System Supporting Review of Presentation Slides for Pharmaceutical Companies

FRONTEO began offering KIBIT BackStage, an AI system that supports pharmaceutical companies in reviewing presentation slides. The AI performs an initial check of items requiring review, while people make the final decisions, supporting more efficient reviews and the sharing of review criteria and knowledge.

Worth reading
46Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.
Direction
Improvement
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Announced details

KIBIT BackStageKIBIT
Applicable field (uses covered by this announcement)

Review of presentation slides for pharmaceutical company seminars and study sessions, and activities to provide pharmaceutical information to healthcare professionals

Launch date15 October 2026 (already launched)

In this announcement the company addresses none of Contract Value / Offering price / Impact on Business Performance.

Source (materials cited by the company)

Ministry of Health, Labour and Welfare, “Guidelines on Activities for Providing Sales Information on Prescription Drugs”

Announced details
ItemDetails
Names of Products / Services CoveredKIBIT BackStage, KIBIT
Launch date15 October 2026 (already launched)
Applicable areaReview of presentation slides for pharmaceutical company seminars and study sessions, and activities to provide pharmaceutical information to healthcare professionals
SourceMinistry of Health, Labour and Welfare, “Guidelines on Activities for Providing Sales Information on Prescription Drugs”
Items this document does not state (14)
CounterpartyCounterparty overviewRelationship with the CompanyContract ValueOffering priceContract DateAward/certification nameAwarding / certifying bodyRegistration number and expiry dateLocationLocation scaleQuantitative EffectsUsage historyImpact on Business Performance

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

Because reviewing presentation slides for pharmaceutical company seminars requires checks covering a wide range of areas, including internal rules and guidelines, the content of the slides, and cited references, resulting in increased workloads, overlooked risks, and inconsistencies in judgments among those responsible.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
FRONTEO Launches KIBIT BackStage, an AI System Supporting Review of Presentation Slides for Pharmaceutical Companies | FRONTEO,Inc. (2158) timely disclosure | Komori